Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Meredith

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Journal of Pharmaceutical Sciences|May 1, 1993
A novel statistical approach for the comparison of analytical methods to measure angiotensin converting enzyme activity, enalaprilat, and benazeprilatJ R Wade, D M Hughes, A W Kelman, et al.
American Journal of Therapeutics|August 1, 1995
The Effects of Age on the Pharmacokinetics and Pharmacodynamics of Cardiovascular Drugs: Application of Concentration-Effect Modeling. 2. AcebutololP. J.W. Scott, P. A. Meredith, A. W. Kelman, et al.
British Journal of Clinical Pharmacology|June 1, 1991
The effect of renal impairment on the pharmacokinetics and metabolism of bopindololN J MacDonald, A C Grant, R S Rodger, et al.
British Journal of Clinical Pharmacology|November 1, 1991
Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjectsR F Schafers, H L Elliott, P A Meredith, et al.
International Journal of Clinical Pharmacology Research|January 1, 1984
Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensivesH L Elliott, P A Meredith, C W Howden, et al.
American Journal of Therapeutics|August 1, 1995
The Effects of Age on the Pharmacokinetics and Pharmacodynamics of Cardiovascular Drugs: Application of Concentration-Effect Modeling. 1. TolmesoxideP. A. Meredith, P. J.W. Scott, A. W. Kelman, et al.
British Journal of Clinical Pharmacology|May 1, 1987
Adimolol, a long acting beta-adrenoceptor blocker in manH L Elliott, C R Jones, N M Deighton, et al.
British Journal of Clinical Pharmacology|July 1, 1983
The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjectsP A Meredith, H L Elliott, D R McSharry, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 1978
The association between lead concentrations in teeth and domestic water lead concentrationsM R Moore, B C Campbell, P A Meredith, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 2, 1979
The contribution of drinking water lead to maternal blood lead concentrationsM R Moore, A Goldberg, P A Meredith, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Journal of Pharmaceutical Sciences|May 1, 1993
A novel statistical approach for the comparison of analytical methods to measure angiotensin converting enzyme activity, enalaprilat, and benazeprilatJ R Wade, D M Hughes, A W Kelman, et al.
American Journal of Therapeutics|August 1, 1995
The Effects of Age on the Pharmacokinetics and Pharmacodynamics of Cardiovascular Drugs: Application of Concentration-Effect Modeling. 2. AcebutololP. J.W. Scott, P. A. Meredith, A. W. Kelman, et al.
British Journal of Clinical Pharmacology|June 1, 1991
The effect of renal impairment on the pharmacokinetics and metabolism of bopindololN J MacDonald, A C Grant, R S Rodger, et al.
British Journal of Clinical Pharmacology|November 1, 1991
Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjectsR F Schafers, H L Elliott, P A Meredith, et al.
International Journal of Clinical Pharmacology Research|January 1, 1984
Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensivesH L Elliott, P A Meredith, C W Howden, et al.
American Journal of Therapeutics|August 1, 1995
The Effects of Age on the Pharmacokinetics and Pharmacodynamics of Cardiovascular Drugs: Application of Concentration-Effect Modeling. 1. TolmesoxideP. A. Meredith, P. J.W. Scott, A. W. Kelman, et al.
British Journal of Clinical Pharmacology|May 1, 1987
Adimolol, a long acting beta-adrenoceptor blocker in manH L Elliott, C R Jones, N M Deighton, et al.
British Journal of Clinical Pharmacology|July 1, 1983
The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjectsP A Meredith, H L Elliott, D R McSharry, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 1978
The association between lead concentrations in teeth and domestic water lead concentrationsM R Moore, B C Campbell, P A Meredith, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 2, 1979
The contribution of drinking water lead to maternal blood lead concentrationsM R Moore, A Goldberg, P A Meredith, et al.
Pageof 21